Cochrane Abstracts
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aminoadamantanes Versus Other Antiviral Drugs for Chronic Hepatitis C." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Aminoadamantanes_versus_other_antiviral_drugs_for_chronic_hepatitis_C.
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Aminoadamantanes_versus_other_antiviral_drugs_for_chronic_hepatitis_C. Accessed January 16, 2026.
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Aminoadamantanes_versus_other_antiviral_drugs_for_chronic_hepatitis_C
Aminoadamantanes Versus Other Antiviral Drugs for Chronic Hepatitis C [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Aminoadamantanes_versus_other_antiviral_drugs_for_chronic_hepatitis_C.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aminoadamantanes versus other antiviral drugs for chronic hepatitis C
ID - 435060
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Aminoadamantanes_versus_other_antiviral_drugs_for_chronic_hepatitis_C
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
